rs201636741
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The ENST00000258173.11(TMEM231):c.498G>A(p.Pro166=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00082 in 1,605,626 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0043 ( 5 hom., cov: 21)
Exomes 𝑓: 0.00047 ( 3 hom. )
Consequence
TMEM231
ENST00000258173.11 synonymous
ENST00000258173.11 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.67
Genes affected
TMEM231 (HGNC:37234): (transmembrane protein 231) This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 16-75545436-C-T is Benign according to our data. Variant chr16-75545436-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 385987.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00428 (638/149212) while in subpopulation AFR AF= 0.0144 (583/40402). AF 95% confidence interval is 0.0135. There are 5 homozygotes in gnomad4. There are 315 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.498G>A | p.Pro166= | synonymous_variant | 4/7 | ENST00000258173.11 | NP_001070886.1 | |
TMEM231 | NM_001077416.2 | c.657G>A | p.Pro219= | synonymous_variant | 3/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.664G>A | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000258173.11 | c.498G>A | p.Pro166= | synonymous_variant | 4/7 | 1 | NM_001077418.3 | ENSP00000258173 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00429 AC: 639AN: 149096Hom.: 5 Cov.: 21
GnomAD3 genomes
AF:
AC:
639
AN:
149096
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00121 AC: 300AN: 246996Hom.: 0 AF XY: 0.000999 AC XY: 134AN XY: 134068
GnomAD3 exomes
AF:
AC:
300
AN:
246996
Hom.:
AF XY:
AC XY:
134
AN XY:
134068
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000466 AC: 678AN: 1456414Hom.: 3 Cov.: 28 AF XY: 0.000407 AC XY: 295AN XY: 724352
GnomAD4 exome
AF:
AC:
678
AN:
1456414
Hom.:
Cov.:
28
AF XY:
AC XY:
295
AN XY:
724352
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00428 AC: 638AN: 149212Hom.: 5 Cov.: 21 AF XY: 0.00434 AC XY: 315AN XY: 72662
GnomAD4 genome
AF:
AC:
638
AN:
149212
Hom.:
Cov.:
21
AF XY:
AC XY:
315
AN XY:
72662
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 11, 2023 | BS1, PP3 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 27, 2018 | - - |
not specified Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 21, 2022 | - - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at